Drug · DIN 02237320
REBIF
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 24, 1998; first marketed February 24, 1998.
- Drug Identification Number (DIN)
- 02237320
- Company (DIN owner)
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Interferon beta-1a L03AB07
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INTERFERON BETA-1A | 44 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 5, 1998: NOC 2996New Drug Submission (NDS)
Other DINs named REBIF
- DIN 02237319 · Marketed
- DIN 02318253 · Marketed
- DIN 02318261 · Marketed
- DIN 02237317 · Cancelled Post Market
- DIN 02277492 · Cancelled Post Market
- DIN 02281708 · Cancelled Post Market
- DIN 02318288 · Cancelled Pre Market